Perceptive Advisors LLC 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-22 4:34 pm Purchase | 2026-01-14 | 13G | SAB Biotherapeutics, Inc. SABS | Perceptive Advisors LLC | 3,471,861 7.300% | 3,471,861 (New Position) | Filing |